Top Tweets for #PYPB

about 1 year ago

$IXI IXICO shares rise 4% on stronger-than-expected revenue growth https://t.co/LpGl3rSptM @IXICOnews $PYPB $PHYOF #IXI #PYPB #PHYOF

0

1

0

347

about 1 year ago

$IXI IXICO shares climb 12% on £1.2m contract wins in biomarker testing https://t.co/xHbhDkdtPF @IXICOnews $PYPB $PHYOF #IXI #PYPB #PHYOF

1

2

1

0

365

about 1 year ago

$IXI IXICO’s competitive edge: Focused expertise in brain disorders - P2 https://t.co/cUG6Ak2Fwb @IXICOnews $PYPB $PHYOF #IXI #PYPB #PHYOF

0

2

1

0

422

over 1 year ago

$IXI IXICO expects 2025 revenues to exceed forecasts as strategy starts to bear fruit https://t.co/SB7eQ9dTLK @IXICOnews $PYPB $PHYOF #IXI #PYPB #PHYOF

0

1

0

416

over 1 year ago

$IXI IXICO supports first US approval of blood test for Alzheimer’s diagnosis https://t.co/j4J2wJarUO @IXICOnews $PYPB $PHYOF #IXI #PYPB #PHYOF

0

2

1

0

169

over 1 year ago

$IXI IXICO says focused strategy has put it on course to exceed full-year expectations https://t.co/QSiI5FHtMJ @IXICOnews $PYPB $PHYOF #IXI #PYPB #PHYOF

0

3

1

0

189

over 4 years ago

$IXI IXICO lands its third Huntington’s Disease contract in two months https://t.co/z1zHU1PwCX @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

2

1

0

over 4 years ago

$IXI IXICO lands £800,000 Huntington's contract https://t.co/9ScuWqei0J @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

2

1

0

over 4 years ago

$IXI IXICO wins £800,000 Huntington's disease trial https://t.co/kzV6UBhJOm @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

2

3

0

over 4 years ago

$IXI IXICO hails the introduction of https://t.co/TeRg2RQ5Mq, its new brain imaging technology https://t.co/ptc5VRLtxL @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

3

1

0

over 4 years ago

$IXI Ixico names Dr Lynne Hughes as senior therapeutic advisor https://t.co/GVO5kpZPrn @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

2

0

almost 5 years ago

$IXI IXICO mark 'fifth year of successive EBITDA growth' and hail 'great market opportunity ahead' https://t.co/BLqmbY97kr @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

2

0

almost 5 years ago

$IXI IXICO inks neuroimaging deal for phase III demyelinating disorder study https://t.co/dVKSKnKpeg @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

1

0

about 5 years ago

$IXI IXICO lands US$750,000, two-year deal with top-five contract research group https://t.co/DZn5ZipJwD @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB

0

about 5 years ago

$IXI IXICO to provide its expertise to a clinical trial of a treatment multiple system atrophy https://t.co/AsbFjROSFg @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

1

0

about 5 years ago

$IXI Ixico set to return to double digit growth in 2022 as impact of Covid-19 on drug trials eases https://t.co/fHYBSaN6Gj @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

2

1

0

over 5 years ago

$IXI IXICO contract win is "strong endorsement" and supports growth strategy, says broker https://t.co/pVS4bOBhY3 @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB

0

2

0

over 5 years ago

$IXI IXICO contract win is "strong endorsement" and supports growth strategy, says broker https://t.co/DPDoX9IAfY @IXICOnews $PHYOF $PYPB #IXI #PHYOF #PYPB #Katie_Proactive

0

3

1

0